Thomas G. Beach

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.

Evidence for an association between KIBRA and late-onset Alzheimer's disease.

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.

Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.

Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease.

Induction of pluripotent stem cells from autopsy donor-derived somatic cells.

Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease.

Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Alzheimer's disease and the "Valley Of Death": not enough guidance from human brain tissue?

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis.

Submandibular gland biopsy for the diagnosis of Parkinson disease.

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.

Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes.

PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease.

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.

Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease.

The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.

Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson's Disease.

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.

A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Association of AEBP1 and NRN1 RNA expression with Alzheimer's disease and neurofibrillary tangle density in middle temporal gyrus.

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.